跳至主要内容
临床试验/ACTRN12606000349549
ACTRN12606000349549已完成不适用

A randomised clinical trial of computerised cognitive behaviour therapy (CBT) for the treatment of anxiety disorders and effects on neuropsychological functioning and plasma oxytocin levels

niversity of Otago, New Zealand0 个研究点目标入组 200 人开始时间: 2006年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Current Diagnostic and Statistical Manual of Mental Disorders (DSM IV ) primary diagnosis of panic disorder, social phobia or generalised anxiety disorderAccess to the internet and sufficient competency with English language.

排除标准

  • DSM IV primary diagnosis of obsessive compulsive disorder, specific phobia or post traumatic stress disorder (PTSD)Current diagnosis of psychotic illness, bipolar 1 disorder, alcohol or drug dependenceDisabling cardiac or respiratory disordersSerious neurological disordersStarted on or changed dose of antidepressant medication in last 6 weeks.

研究者

发起方
niversity of Otago, New Zealand

相似试验